{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bioequivalence&page=5", "query": { "condition": "Bioequivalence", "page": 5 }, "page_size": 10 }, "pagination": { "page": 5, "page_size": 10, "total_count": 783, "total_pages": 79, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bioequivalence&page=6&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bioequivalence&page=4&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-21T18:19:26.874Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00864162", "title": "A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fed Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Ramipril10 mg Capsules, single dose", "type": "DRUG" }, { "name": "Atlace® 10 mg capsules, single dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Actavis Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 40, "start_date": "2004-09", "completion_date": "2004-10", "has_results": false, "last_update_posted_date": "2010-08-16", "last_synced_at": "2026-10-21T18:19:26.874Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00864162" }, { "nct_id": "NCT00650377", "title": "Fed Study of Finasteride Tablets 5 mg and Proscar® Tablets 5 mg", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Finasteride Tablets 5 mg", "type": "DRUG" }, { "name": "Proscar® Tablets 5 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mylan Pharmaceuticals Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 30, "start_date": "2004-10", "completion_date": "2004-10", "has_results": false, "last_update_posted_date": "2024-04-23", "last_synced_at": "2026-10-21T18:19:26.874Z", "location_count": 1, "location_summary": "Morgantown, West Virginia", "locations": [ { "city": "Morgantown", "state": "West Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00650377" }, { "nct_id": "NCT00649857", "title": "Food Study of Cetirizine HCl Tablets 10 mg and Zyrtec® 10 mg", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Cetirizine HCl Tablets 10 mg", "type": "DRUG" }, { "name": "Zyrtec® 10 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mylan Pharmaceuticals Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 18, "start_date": "2002-11", "completion_date": "2002-12", "has_results": false, "last_update_posted_date": "2024-04-24", "last_synced_at": "2026-10-21T18:19:26.874Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00649857" }, { "nct_id": "NCT06802185", "title": "A Bioequivalence Study of Advil Dual Action Liquid Filled Capsules (125 mg/250 mg) Versus Advil Dual Action Caplets (125 mg/250 mg) and Bioavailability Assessment of Advil Dual Action Liquid Filled Capsules (125 mg/250 mg) and Advil Liqui-Gels (200 mg) in Healthy Adult Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pain" ], "interventions": [ { "name": "ADA Liquid Filled Capsules (Test Product)", "type": "DRUG" }, { "name": "ADA Caplets (Reference Product)", "type": "DRUG" }, { "name": "Advil Liqui-gels (Reference Product)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "HALEON", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 54, "start_date": "2025-01-31", "completion_date": "2025-04-12", "has_results": false, "last_update_posted_date": "2025-04-23", "last_synced_at": "2026-10-21T18:19:26.874Z", "location_count": 1, "location_summary": "West Bend, Wisconsin", "locations": [ { "city": "West Bend", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT06802185" }, { "nct_id": "NCT02791308", "title": "Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Pimecrolimus Cream 1% (Valeant)", "type": "DRUG" }, { "name": "Vehicle cream", "type": "DRUG" }, { "name": "Pimecrolimus Cream, 1%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Actavis Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "12 Years to 90 Years" }, "enrollment_count": 587, "start_date": "2015-02", "completion_date": "2016-07", "has_results": true, "last_update_posted_date": "2020-05-29", "last_synced_at": "2026-10-21T18:19:26.874Z", "location_count": 53, "location_summary": "Anniston, Alabama • Birmingham, Alabama • Mesa, Arizona + 47 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Rogers", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02791308" }, { "nct_id": "NCT00829790", "title": "Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fed Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Doxycycline Monohydrate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Pharmaceuticals USA", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2006-10", "completion_date": "2006-10", "has_results": true, "last_update_posted_date": "2024-08-19", "last_synced_at": "2026-10-21T18:19:26.874Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00829790" }, { "nct_id": "NCT00853268", "title": "Fed Study of Controlled-Release Oxycodone Hydrochloride 40 mg Tablets and OxyContin® 40 mg Tablets", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Controlled-Release Oxycodone Hydrochloride 40 mg", "type": "DRUG" }, { "name": "OxyContin® 40 mg tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mallinckrodt", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 34, "start_date": "2005-04", "completion_date": "2005-04", "has_results": false, "last_update_posted_date": "2016-09-09", "last_synced_at": "2026-10-21T18:19:26.874Z", "location_count": 1, "location_summary": "Springfield, Missouri", "locations": [ { "city": "Springfield", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00853268" }, { "nct_id": "NCT05181215", "title": "Bioequivalence Study of Bafiertam 190 mg and Vumerity® 462 mg Delayed-Release Capsules in Fasting Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Relapsing Remitting Multiple Sclerosis" ], "interventions": [ { "name": "Monomethyl Fumarate 190 Mg", "type": "DRUG" }, { "name": "Diroximel Fumarate 462 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Banner Life Sciences LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 46, "start_date": "2021-05-14", "completion_date": "2021-08-27", "has_results": false, "last_update_posted_date": "2022-01-06", "last_synced_at": "2026-10-21T18:19:26.874Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT05181215" }, { "nct_id": "NCT00865059", "title": "A Relative Bioavailability Study of Gabapentin Tablets 800 mg Under Non-fasting Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Gabapentin 800 mg Tablets, single dose", "type": "DRUG" }, { "name": "NEURONTIN® 800 mg Tablets, single dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Actavis Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2001-02", "completion_date": "2001-03", "has_results": false, "last_update_posted_date": "2010-08-17", "last_synced_at": "2026-10-21T18:19:26.874Z", "location_count": 1, "location_summary": "Fargo, North Dakota", "locations": [ { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00865059" }, { "nct_id": "NCT00648024", "title": "Fasting Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mg", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Anagrelide Hydrochloride Capsules 1 mg", "type": "DRUG" }, { "name": "Agrylin® Capsules 1 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mylan Pharmaceuticals Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 47, "start_date": "2003-01", "completion_date": "2003-01", "has_results": false, "last_update_posted_date": "2024-04-24", "last_synced_at": "2026-10-21T18:19:26.874Z", "location_count": 1, "location_summary": "Fargo, North Dakota", "locations": [ { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00648024" } ] }